Free Trial

Avadel Pharmaceuticals (AVDL) Insider Trading & Ownership

Avadel Pharmaceuticals logo
$10.31 +0.20 (+1.98%)
(As of 12/20/2024 05:15 PM ET)

Avadel Pharmaceuticals (NASDAQ:AVDL) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.80%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$435,313.04
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1.09 M
Get AVDL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Avadel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AVDL Insider Buying and Selling by Quarter

Avadel Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/13/2024Thomas S MchughCFOBuy2,300$10.44$24,012.00  
12/11/2024Thomas S MchughCFOBuy5,000$10.49$52,450.00  
12/10/2024Geoffrey Michael GlassDirectorBuy20,279$9.84$199,545.36  
12/9/2024Gregory J DivisCEOBuy402$9.82$3,947.64  
12/6/2024Gregory J DivisCEOBuy9,598$9.98$95,788.04  
12/6/2024Linda PalczukDirectorBuy3,000$10.19$30,570.00  
1/16/2024Thomas S MchughCFOBuy2,000$14.50$29,000.00  
12/28/2023Mark Anthony MccamishDirectorSell75,000$14.53$1,089,750.00  
(Data available from 1/1/2013 forward)

AVDL Insider Trading Activity - Frequently Asked Questions

The list of insiders at Avadel Pharmaceuticals includes Eric J Ende, Geoffrey Michael Glass, Gregory J Divis, Linda Palczuk, Mark Anthony Mccamish, and Thomas S Mchugh. Learn more on insiders at AVDL.

4.80% of Avadel Pharmaceuticals stock is owned by insiders. Learn more on AVDL's insider holdings.

The following insiders have purchased AVDL shares in the last 24 months: Geoffrey Michael Glass ($387,145.36), Gregory J Divis ($231,735.68), Linda Palczuk ($81,870.00), and Thomas S Mchugh ($134,362.00).

Insiders have purchased a total of 73,079 AVDL shares in the last 24 months for a total of $835,113.04 bought.

The following insider sold AVDL shares in the last 24 months: Mark Anthony Mccamish ($1,089,750.00).

Insiders have sold a total of 75,000 Avadel Pharmaceuticals shares in the last 24 months for a total of $1,089,750.00 sold.

Avadel Pharmaceuticals Key Executives

  • Mr. Gregory J. Divis Jr. (Age 57)
    CEO & Director
    Compensation: $985.2k
    2 recent trades
  • Mr. Thomas S. McHugh (Age 59)
    Senior VP, Principal Financial and Accounting Officer & CFO
    Compensation: $663.14k
    2 recent trades
  • Mr. Richard J. Kim (Age 55)
    Chief Commercial Officer
    Compensation: $770.95k
  • Mr. Jerad G. Seurer (Age 51)
    General Counsel & Company Secretary
  • Mr. Gregory J. Davis (Age 59)
    VP of Corporate and Business Development
    2 recent trades
  • Mr. Mark W. Elrod
    Vice President of Sales
  • Ms. Angie Woods
    Vice President of People & Culture
  • Dr. Jordan S. Dubow M.D. (Age 46)
    Consultant
    Compensation: $727.93k
  • Dr. Jason M. Vaughn
    Senior Vice President of Technical Operations
  • Ms. Jennifer Gudeman PharmD
    Senior Vice President of Medical & Clinical Affairs


This page (NASDAQ:AVDL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners